OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing
Prasath Pararajalingam, Krysta M. Coyle, Sarah E. Arthur, et al.
Blood (2020) Vol. 136, Iss. 5, pp. 572-584
Open Access | Times Cited: 52
Prasath Pararajalingam, Krysta M. Coyle, Sarah E. Arthur, et al.
Blood (2020) Vol. 136, Iss. 5, pp. 572-584
Open Access | Times Cited: 52
Showing 26-50 of 52 citing articles:
Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands
Daniel Kwon, Katsuyoshi Takata, Zhengxing Zhang, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 8, pp. 1628-1639
Open Access | Times Cited: 8
Daniel Kwon, Katsuyoshi Takata, Zhengxing Zhang, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 8, pp. 1628-1639
Open Access | Times Cited: 8
RNA-binding proteins as drivers of AML and novel therapeutic targets
Tingyu Qin, Ying Cheng, Xiaozhong Wang
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 5, pp. 1045-1057
Closed Access | Times Cited: 8
Tingyu Qin, Ying Cheng, Xiaozhong Wang
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 5, pp. 1045-1057
Closed Access | Times Cited: 8
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Ciara L. Freeman, Prasath Pararajalingam, Ling Jin, et al.
Leukemia (2022) Vol. 36, Iss. 10, pp. 2479-2487
Closed Access | Times Cited: 7
Ciara L. Freeman, Prasath Pararajalingam, Ling Jin, et al.
Leukemia (2022) Vol. 36, Iss. 10, pp. 2479-2487
Closed Access | Times Cited: 7
EZH2 expression is associated with inferior overall survival in mantle cell lymphoma
Diana Lucía Martínez-Baquero, Ali Sakhdari, Huan Mo, et al.
Modern Pathology (2021) Vol. 34, Iss. 12, pp. 2183-2191
Open Access | Times Cited: 9
Diana Lucía Martínez-Baquero, Ali Sakhdari, Huan Mo, et al.
Modern Pathology (2021) Vol. 34, Iss. 12, pp. 2183-2191
Open Access | Times Cited: 9
Etodolac improves collagen induced rheumatoid arthritis in rats by inhibiting synovial inflammation, fibrosis and hyperplasia
Feng Qin, Wenkai Xia, Shenglan Wang, et al.
Molecular Biomedicine (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Feng Qin, Wenkai Xia, Shenglan Wang, et al.
Molecular Biomedicine (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma
Zhongqi Li, Fang Yu, Wenle Ye, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 8
Zhongqi Li, Fang Yu, Wenle Ye, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 8
Prognostic Value of Heterogeneity Index Derived from Baseline 18F-FDG PET/CT in Mantle Cell Lymphoma
Fei Liu, Bingxin Gu, Nan Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Fei Liu, Bingxin Gu, Nan Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Emerging roles for heterogeneous ribonuclear proteins in normal and malignant B cells
Qurat Ul Ain Qureshi, Timothy E. Audas, Ryan D. Morin, et al.
Biochemistry and Cell Biology (2023) Vol. 101, Iss. 2, pp. 160-171
Open Access | Times Cited: 3
Qurat Ul Ain Qureshi, Timothy E. Audas, Ryan D. Morin, et al.
Biochemistry and Cell Biology (2023) Vol. 101, Iss. 2, pp. 160-171
Open Access | Times Cited: 3
Progress in molecular feature of smoldering mantle cell lymphoma
Panruo Jiang, Aakash Desai, Haige Ye
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Panruo Jiang, Aakash Desai, Haige Ye
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets
Joana Rodrigues, Anna Porwit, May Hassan, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 62, Iss. 11, pp. 2637-2647
Open Access | Times Cited: 6
Joana Rodrigues, Anna Porwit, May Hassan, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 62, Iss. 11, pp. 2637-2647
Open Access | Times Cited: 6
RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies
Zhenzhen Li, Zhongzheng He, Jihan Wang, et al.
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 2, pp. 149-163
Closed Access | Times Cited: 2
Zhenzhen Li, Zhongzheng He, Jihan Wang, et al.
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 2, pp. 149-163
Closed Access | Times Cited: 2
Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma
Esra Esmeray Sönmez, Tevfik Hatipoğlu, Deniz Kurşun, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3394-3394
Open Access | Times Cited: 3
Esra Esmeray Sönmez, Tevfik Hatipoğlu, Deniz Kurşun, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3394-3394
Open Access | Times Cited: 3
Molecular Pathogenesis of B-Cell Lymphomas
Laura Pasqualucci, Pantaleo De Simone, Riccardo Dalla‐Favera
Elsevier eBooks (2024), pp. 309-333
Closed Access
Laura Pasqualucci, Pantaleo De Simone, Riccardo Dalla‐Favera
Elsevier eBooks (2024), pp. 309-333
Closed Access
Resistance to PSEN1-selective γ-secretase inhibitors in T-cell acute lymphoblastic leukemia
Charlien Vandersmissen, Sofie Demeyer, Kris Jacobs, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Charlien Vandersmissen, Sofie Demeyer, Kris Jacobs, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pretreatment with BTK inhibitors could improve the sensitivity of DLBCL cells to CAR-T cells in co-culture system by down-regulating the polarization of M2 macrophages
Qi Deng, Yao Qi, Jia Wang, et al.
Research Square (Research Square) (2024)
Open Access
Qi Deng, Yao Qi, Jia Wang, et al.
Research Square (Research Square) (2024)
Open Access
Alternative Splicing: A Potential Therapeutic Target in Hematological Malignancies
Gazmend Temaj, Silvia Chichiarelli, Sarmistha Saha, et al.
Hematology Reports (2024) Vol. 16, Iss. 4, pp. 682-697
Open Access
Gazmend Temaj, Silvia Chichiarelli, Sarmistha Saha, et al.
Hematology Reports (2024) Vol. 16, Iss. 4, pp. 682-697
Open Access
Circulating Tumor DNA Determinants of Response and Outcome in Relapsed/Refractory Mantle Cell Lymphoma
Leo Meriranta, Rasmus Rask Kragh Jørgensen, Annika Pasanen, et al.
Research Square (Research Square) (2024)
Open Access
Leo Meriranta, Rasmus Rask Kragh Jørgensen, Annika Pasanen, et al.
Research Square (Research Square) (2024)
Open Access
REGγ promotes mantle cell lymphoma cell apoptosis by downregulating NF-κB signaling
Xinxin Zeng, Wan-Wei Guo, Ju Shen, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 2, pp. 310-320
Open Access | Times Cited: 1
Xinxin Zeng, Wan-Wei Guo, Ju Shen, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 2, pp. 310-320
Open Access | Times Cited: 1
Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms
Graham W. Slack
Surgical pathology clinics (2023) Vol. 16, Iss. 2, pp. 433-442
Closed Access | Times Cited: 1
Graham W. Slack
Surgical pathology clinics (2023) Vol. 16, Iss. 2, pp. 433-442
Closed Access | Times Cited: 1
Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers
Anna Petráčková, Jakub Savara, Peter Turcsányi, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 3, pp. 371-381
Closed Access | Times Cited: 2
Anna Petráčková, Jakub Savara, Peter Turcsányi, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 3, pp. 371-381
Closed Access | Times Cited: 2
The different flavors and splices of MCL
Oliver Weigert
Blood (2020) Vol. 136, Iss. 5, pp. 526-527
Open Access | Times Cited: 1
Oliver Weigert
Blood (2020) Vol. 136, Iss. 5, pp. 526-527
Open Access | Times Cited: 1
Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesis
Heiko Müller, Wencke Walter, Stephan Hütter, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 5, pp. 484-493
Open Access | Times Cited: 1
Heiko Müller, Wencke Walter, Stephan Hütter, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 5, pp. 484-493
Open Access | Times Cited: 1
The pathological and clinical heterogeneity of mantle cell lymphoma
Marco M. Bühler, Elı́as Campo
Diagnostic histopathology (2023) Vol. 29, Iss. 5, pp. 246-251
Closed Access
Marco M. Bühler, Elı́as Campo
Diagnostic histopathology (2023) Vol. 29, Iss. 5, pp. 246-251
Closed Access
Targeting NOTCH in Lymphoid Malignancies
Deborah Piffaretti, G. Galimberti, and Davide Rossi
(2023), pp. 411-427
Closed Access
Deborah Piffaretti, G. Galimberti, and Davide Rossi
(2023), pp. 411-427
Closed Access
HNRNPH1 destabilizes the G-quadruplex structures formed by G-rich RNA sequences that regulate the alternative splicing of an oncogenic fusion transcript
Tam Vo, Tayvia Brownmiller, Katherine L. Hall, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Tam Vo, Tayvia Brownmiller, Katherine L. Hall, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
